[HTML][HTML] Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients

R Rosas-Alonso, J Colmenarejo-Fernandez… - Clinical …, 2021 - Springer
Background The promoter hypermethylation of the methylguanine-DNA methyltransferase
gene is a frequently used biomarker in daily clinical practice as it is associated with a …

[HTML][HTML] A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response

O Pernía, A Sastre-Perona, C Rodriguez-Antolín… - Cancers, 2020 - mdpi.com
Despite often leading to platinum resistance, platinum-based chemotherapy continues to be
the standard treatment for many epithelial tumors. In this study we analyzed and validated …

Novel SLC12A2-ROS1 fusion in non-small cell lung cancer with a significant response to crizotinib: the importance of choosing the appropriate next-generation …

C Rodríguez-Antolín, R Rosas-Alonso, P Cruz… - The …, 2021 - academic.oup.com
Identifying the druggable target is crucial for patients with nonsquamous advanced non-
small cell lung cancer (NSCLC). This article adds to the spectrum of ROS1 fusion cases …

[HTML][HTML] Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer?

J Peña-López, D Jiménez-Bou, I Ruíz-Gutiérrez… - Cancers, 2024 - mdpi.com
Simple Summary Colorectal cancer is often associated with MUTYH mutations, but their
connection to breast cancer remains unclear. We aimed to assess if MUTYH mutations …

# 596 One-centre based real-world data on treatment and disease evolution in BRCA germline mutated and non-mutated epithelial ovarian cancer

I Ruiz-Gutierrez, D Martinez-Perez, M Alonso-Espias… - 2023 - ijgc.bmj.com
Introduction/Background Between 10–15% of patients with epithelial ovarian cancer (EOC)
carry a germline mutation in BRCA1/2. Different studies suggest that this population has a …

[HTML][HTML] miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients

D Sanchez-Cabrero, Á Garcia-Guede… - International Journal of …, 2023 - mdpi.com
Despite advances in non-small cell lung cancer (NSCLC) research, this is still the most
common cancer type that has been diagnosed up to date. microRNAs have emerged as …

[HTML][HTML] 482 COVID-19 in patients with lung cancer receiving immunotherapy. A report from an spanish academic center

D Viñal, L Gutierrez, J Villamayor, O Higuera… - 2020 - jitc.bmj.com
Background COVID-19, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was declared pandemic in March 2020. We know that patients with cancer …

miRNome exosomal characterization reveals a distinct signature able to predict cisplatin-response in NSCLC patients

M Burdiel, J Jimenez, C Rodriguez-Antolin, O Pernia… - Cancer Research, 2021 - AACR
Background: Non-small cell lung cancer (NSCLC) is one leading cause of death worldwide,
with a 5-year survival rate of only 24%. Late diagnosis and the innate or acquired anti …

MP44-20 MALE-CARRIERS OF GENE MUTATIONS ASSOCIATED WITH INCREASED RISK OF PROSTATE CANCER: RESULTS FROM A SINGLE INSTITUTION …

E Linares-Espinós, L Ruiz-Gimenez, E Rios… - The Journal of …, 2023 - auajournals.org
INTRODUCTION AND OBJECTIVE: Current international guidelines address genetic
counseling for patients with Prostate Cancer (PCa) and family history and/or metastatic PCa …

Dietitian-nutritionist incorporation in a university hospital: position statement of the Commission on Nutrition, Hospital Universitario La Paz

MV Pérez, MS de Pipaon, MM Martínez… - … : Organo oficial de la …, 2024 - dialnet.unirioja.es
El presente documento tiene como objetivo plantear y justificar la incorporación del dietista-
nutricionista en los equipos multidisciplinares de atención integrada en la educación, el …